Prefilled Syringes Market Size & Share, by Design (Single-Chamber, Dual Chamber, Customized); Material (Glass-Based, Plastic Based); Application (Diabetes, Multiple Sclerosis, Anaphylaxis, Cancer) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4398
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Prefilled Syringes Landscape

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer Pharmaceuticals
    • Baxter BioPharma Solutions
    • BG (Becton, Dickinson and Company)
    • Gerresheimer AG
    • Medtronic
    • Nipro Pharma Corporation
    • Terumo Medical Corporation
    • Vetter Pharma International GmbH
    • West Pharmaceutical Services, Inc.

Browse Key Market Insights with Data Illustration:


In The News

  •  Baxter BioPharma Solutions a pioneer in the delivery and production of sterile drugs expanded its sterile fill/finish manufacturing facilities located in Bloomington, Ind. Further, a high-speed automated syringe fills line with a fill rate of up to 600 units per minute, and a new high-speed automated visual inspection line were all part of the facility's planned infrastructure expansion.

  • BG (Becton, Dickinson and Company) introduced BD Effivax Glass Prefillable Syringe to establish a new benchmark for vaccine PFS performance. Further, it is expected to provide clients with additional support to handle the demanding requirements of today's vaccine manufacturing through design improvements targeted at fill/finish and container dependability.


Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4398
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of HIV and hepatitis-B cases and the rise in demand of self-injection devices are the major factors driving the market growth.

The market size of prefilled syringes is anticipated to attain a CAGR of ~13% over the forecast period, i.e., 2023-2033.

Leakage in the syringes and the strict regulations associated with the production of syringes are estimated to be the growth hindering factors for the market expansion.

The market in the Europe region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Abbott, Bayer Pharmaceuticals, Baxter BioPharma Solutions, BG (Becton, Dickinson and Company), Gerresheimer AG, Medtronic, Nipro Pharma Corporation, Terumo Medical Corporation, Vetter Pharma International GmbH, West Pharmaceutical Services, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by design, material, application, and by region.

The diabetes segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying